Literature DB >> 12957502

Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome.

Stefan Leis1, Margarete Weber, Andreas Isselmann, Martin Schmelz, Frank Birklein.   

Abstract

Pain, mechanical hyperalgesia, edema, increased skin temperature, and skin reddening are characteristic symptoms of acute complex regional pain syndrome (CRPS). We have recently demonstrated facilitated neurogenic inflammation on the affected limb. To further elucidate the underlying mechanisms, exogenous substance P (SP) in ascending concentrations (10(-9), 10(-8), 10(-7), 10(-6) M) was intradermally applied to the affected and the unaffected limbs, respectively, in two groups of 11 CRPS patients each using the microdialysis technique. Fourteen healthy volunteers served as controls for SP application, and 9 volunteers and 10 patients served as controls for saline perfusion. Dialysate protein content was measured photometrically to assess plasma protein extravasation. Significant differences in dialysate protein content were found after 10(-9) M SP (affected side, 98.4 +/- 8.4% of baseline value; unaffected side, 104.4 +/- 5.6%; controls, 70.7 +/- 4.1%; P < 0.005) and after 10(-6) M SP (affected, 169.7 +/- 24.2%; unaffected, 189.4 +/- 19.1%; controls, 122.2 +/- 12.0%; P < 0.05). While 10(-9) M SP induced no protein extravasation in controls, it provoked protein extravasation in 6 of 11 patients on the affected and in 5 of 11 patients on the unaffected side (P < 0.01). We conclude that SP-induced plasma protein extravasation is increased in CRPS patients on both the affected and unaffected limbs. The underlying mechanism might be impaired SP inactivation. Thus, our results further support the hypothesis that neurogenic inflammation plays an important role in the initiation of CRPS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957502     DOI: 10.1016/s0014-4886(03)00163-8

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  30 in total

1.  Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.

Authors:  Xiaoyou Shi; Liping Wang; J David Clark; Wade S Kingery
Journal:  Regul Pept       Date:  2013-08-17

Review 2.  [Current aspects of the therapy of complex regional pain syndrome].

Authors:  F Birklein; T Schlereth
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

3.  Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.

Authors:  Tian-Zhi Guo; Tzuping Wei; Wen-Wu Li; Xiang-Qi Li; J David Clark; Wade S Kingery
Journal:  J Pain       Date:  2014-07-22       Impact factor: 5.820

Review 4.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

Review 5.  Complex regional pain syndrome.

Authors:  Frank Birklein
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

Review 6.  Mechanism-based treatment in complex regional pain syndromes.

Authors:  Janne Gierthmühlen; Andreas Binder; Ralf Baron
Journal:  Nat Rev Neurol       Date:  2014-08-19       Impact factor: 42.937

Review 7.  [Complex regional pain syndrome: A current review].

Authors:  C Maihöfner
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

8.  Gardner-Diamond syndrome associated with complex regional pain syndrome.

Authors:  Lara K Edinger; Robert J Schwartzman
Journal:  J Dermatol Case Rep       Date:  2013-03-30

9.  Activation of cutaneous immune responses in complex regional pain syndrome.

Authors:  Frank Birklein; Peter D Drummond; Wenwu Li; Tanja Schlereth; Nahid Albrecht; Philip M Finch; Linda F Dawson; J David Clark; Wade S Kingery
Journal:  J Pain       Date:  2014-01-23       Impact factor: 5.820

10.  Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.

Authors:  Wenwu Li; Xiaoyou Shi; Liping Wang; Tianzhi Guo; Tzuping Wei; Kejun Cheng; Kenner C Rice; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2013-04-12       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.